By Bill Rusteberg
I conducted a price check today in a small two prescription drug store town in central Texas. I had been getting the prescription at a third pharmacy in town but they closed their doors several weeks ago. The price there was $22.
Continue reading Drug Price Check In Cuero, Texas
“Readers digest version: if you try to bring in your own oversight, you’ll either face enough friction to give up—or pay steeply for the privilege. Whether the intent is deterrence, revenue extraction, or both, the result is the same.”
Continue reading Good Luck In Auditing Your Blue Cross ClaimsBy Katie Palmer
Hundreds of telehealth companies, concierge medical practices, and medical spas have over the last few years built huge businesses offering compounded versions of popular GLP-1 obesity drugs while branded versions were in shortage.
In more than 50 warning letters sent last week and published on Tuesday, the FDA took these health providers and companies to task for false and misleading claims about the compounded products they market.
Continue reading GLP-1 Compound Drugs Is BIG BUSINESSBy Alan Goforth
Primary care has been shown to improve health outcomes and population health; reduce health disparities; and save money. Despite these benefits, however, accessing primary care has become more difficult.
Continue reading Primary Care Shortage Worsens
Study shows that compared with GLP-1 RAs, bariatric surgery was significantly associated with greater weight loss while saving approximately $11,689 in ongoing costs over 2 years.
Continue reading Bariatric Surgery Beats GLP-1s in Greater Weight Loss While Saving Over $11,000
SOURCE: 46 Brookyln
Continue reading Track Drug Prices Here
Early this week, we released our review of four months of brand drug list price changes and generic drug acquisition cost trends. With brand list price changes ranging from as low as a 76% decrease and as high as a whopping 1,224% increase, there were plenty of eyebrow-raisers in the report.
